- Acquired by MBody AI, Sep 2025
- Raised $10M Follow-on PO led by Northland Capital Markets, Aug 2026
- Raised $10M Follow-on PO, Mar 2022
About
Check-Cap Ltd. was an Israeli clinical-stage medical diagnostics company based in Isfiya, Israel, focused on developing innovative diagnostic imaging tools for the early detection of colorectal cancer. Its flagship product, the C-Scan® System, is a non-invasive, capsule-based colon imaging technology designed for individuals at average risk who may not comply with traditional screening methods. This system uses an ingestible capsule with ultra-low dose X-ray technology to create detailed maps of the colon. The C-Scan® System is not approved in the United States and is currently an investigational device. Check-Cap is currently undergoing a strategic transformation through a merger with MBody AI Corp., aiming to become a publicly traded leader in embodied artificial intelligence, delivering enterprise-grade AI orchestration for robotic systems across various industries. The combined company will change its name to MBody AI Ltd. and will continue to retain Check-Cap's medical diagnostic assets, including its intellectual property portfolio.
Funding history · 5 rounds · $50.2M total
Headcount over time
Offices
Q&A
- What is Check-Cap's current status?
- Check-Cap was acquired by MBody AI on September 2025.
- What is Check-Cap's primary focus?
- Check-Cap was a clinical-stage medical diagnostics company focused on developing a non-invasive, capsule-based system for colorectal cancer screening. Following its merger with MBody AI Corp., the combined company aims to be a leader in embodied artificial intelligence for robotic systems, while retaining Check-Cap's medical diagnostic assets.
- When was Check-Cap founded?
- Check-Cap was founded in 2004.
- What was the total amount of funding raised by Check-Cap?
- Check-Cap raised a total of $134.22 million USD.
- Who are the lead investors in Check-Cap's 2021 C Round?
- The lead investors in Check-Cap's C Round in 2021 were GE Healthcare and Pontifax.
- What is the employee count for Check-Cap?
- Check-Cap has 11-50 employees.
- When did Check-Cap announce a review of strategic alternatives and workforce reduction?
- Check-Cap announced a review of strategic alternatives and a reduction in its workforce on June 6, 2023.
- When did Check-Cap and MBody AI enter into a definitive merger agreement?
- MBody AI and Check-Cap entered into a definitive merger agreement on September 12, 2025.
Team · 4
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | check-cap.com |
|---|---|
| linkedin.com/company/10085721 | |
| facebook.com/CheckCapLTD | |
| YouTube | youtube.com/channel/UC3n5N9eHCkwUyuEaSDQiXlA |
| Wikidata | wikidata.org/wiki/Q33121693 |
Identifiers & details
| Legal name | MBody AI Ltd. |
|---|---|
| Founded | 2004 |
| Employees (exact) | 85 |
| Market cap | $9.4M |
| Status reason | Acquired by MBody AI on Sep, 2025 |
| Wikidata QID | Q33121693 |
Acquisitions & public offerings
Acquired by MBody AI 2025-09
Radar intelligence
Patents
| EPO | 33 |
|---|
Web history (Wayback)
| Domain | check-cap.com |
|---|
Wikidata
| QID | Q33121693 |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514259811 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 2009-04-05 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 1 — violation (1) |
| Registered address | שד אבא חושי 29 עספיא |
Recent registry events
| Date | Event |
|---|---|
| 2026-05-26 | עדכון הפרה |